Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway.

Abstract : Berberine (BBR), one of the major constituents of Chinese herb Rhizoma coptidis, has been reported to exert beneficial effects to various diseases, including Alzheimer's disease (AD). In the present work, we aimed to investigate the effects of BBR on neuronal cell death induced by homocysteic acid (HCA), which was considered as a risk of AD. BBR significantly reduced HCA-induced reactive oxygen species (ROS) generation, lactate dehydrogenase release and subsequent cell death. LY294002, the PI3K inhibitor, blocked the protection as well as the up-regulation of Akt phosphorylation of BBR. Taken together, our results indicate that BBR protects HCA-induced HT-22 cell death partly via modulating Akt pathway, suggesting BBR may be a promising therapeutic agent for the treatment of HCA-related diseases, including AD.
Type de document :
Article dans une revue
Metabolic Brain Disease, Springer Verlag, 2015, 30 (1), pp.137-42. 〈10.1007/s11011-014-9580-x〉
Liste complète des métadonnées

https://hal-riip.archives-ouvertes.fr/pasteur-01135521
Contributeur : Michel Courcelles <>
Soumis le : mercredi 25 mars 2015 - 14:15:19
Dernière modification le : jeudi 22 octobre 2015 - 12:38:38

Identifiants

Collections

Citation

Meihui Chen, Min Tan, Minghua Jing, Anmin Liu, Qinyu Liu, et al.. Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway.. Metabolic Brain Disease, Springer Verlag, 2015, 30 (1), pp.137-42. 〈10.1007/s11011-014-9580-x〉. 〈pasteur-01135521〉

Partager

Métriques

Consultations de la notice

30